These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1600 related items for PubMed ID: 17570208

  • 1. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS.
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [Abstract] [Full Text] [Related]

  • 2. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, Coleman N, Alexander GJ.
    Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
    [Abstract] [Full Text] [Related]

  • 3. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.
    Yang XH, Yamagiwa S, Ichida T, Matsuda Y, Sugahara S, Watanabe H, Sato Y, Abo T, Horwitz DA, Aoyagi Y.
    J Hepatol; 2006 Aug; 45(2):254-62. PubMed ID: 16600416
    [Abstract] [Full Text] [Related]

  • 4. Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma.
    Fu J, Zhang Z, Zhou L, Qi Z, Xing S, Lv J, Shi J, Fu B, Liu Z, Zhang JY, Jin L, Zhao Y, Lau GK, Zhao J, Wang FS.
    Hepatology; 2013 Jul; 58(1):139-49. PubMed ID: 22961630
    [Abstract] [Full Text] [Related]

  • 5. Increased expression of cyclooxygenase-2 and increased infiltration of regulatory T cells in tumors of patients with hepatocellular carcinoma.
    Gao YW, Chen YX, Wang ZM, Jin J, Li XY, Zhou le D, Huo Z, Zhou JH, Chen W.
    Digestion; 2009 Jul; 79(3):169-76. PubMed ID: 19329856
    [Abstract] [Full Text] [Related]

  • 6. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients.
    Yang ZQ, Yang ZY, Zhang LD, Ping-Bie, Wang SG, Ma KS, Li XW, Dong JH.
    Hum Immunol; 2010 Dec; 71(12):1180-6. PubMed ID: 20870003
    [Abstract] [Full Text] [Related]

  • 7. [Clinical significance of regulatory T cells proportion in the peripheral blood and tumor tissue in primary hepatocellular carcinoma].
    Li SP, Peng QQ, Ding T, Xu J, Zhang CQ, Feng KT, Li JQ.
    Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):523-7. PubMed ID: 19062720
    [Abstract] [Full Text] [Related]

  • 8. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
    Knol AC, Lemaître F, Pandolfino MC, Volteau C, Quéreux G, Saiagh S, Khammari A, Viguier M, Dréno B.
    Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
    [Abstract] [Full Text] [Related]

  • 9. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [Abstract] [Full Text] [Related]

  • 10. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.
    Kobayashi N, Hiraoka N, Yamagami W, Ojima H, Kanai Y, Kosuge T, Nakajima A, Hirohashi S.
    Clin Cancer Res; 2007 Feb 01; 13(3):902-11. PubMed ID: 17289884
    [Abstract] [Full Text] [Related]

  • 11. Increased number of CD25 FoxP3 regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining.
    Schwarz S, Butz M, Morsczeck C, Reichert TE, Driemel O.
    J Oral Pathol Med; 2008 Sep 01; 37(8):485-9. PubMed ID: 18355177
    [Abstract] [Full Text] [Related]

  • 12. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
    Kiniwa Y, Miyahara Y, Wang HY, Peng W, Peng G, Wheeler TM, Thompson TC, Old LJ, Wang RF.
    Clin Cancer Res; 2007 Dec 01; 13(23):6947-58. PubMed ID: 18056169
    [Abstract] [Full Text] [Related]

  • 13. The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma.
    Lee WC, Wu TJ, Chou HS, Yu MC, Hsu PY, Hsu HY, Wang CC.
    Surgery; 2012 Feb 01; 151(2):213-22. PubMed ID: 21975289
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Sasaki A, Tanaka F, Mimori K, Inoue H, Kai S, Shibata K, Ohta M, Kitano S, Mori M.
    Eur J Surg Oncol; 2008 Feb 01; 34(2):173-9. PubMed ID: 17928188
    [Abstract] [Full Text] [Related]

  • 15. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS, Wang J, Shen DF, Yuan XL, Dong P, Li MX, Xue J, Zhang FM, Ge HL, Xu D.
    Clin Immunol; 2009 Apr 01; 131(1):109-18. PubMed ID: 19153062
    [Abstract] [Full Text] [Related]

  • 16. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.
    Li L, Lao SH, Wu CY.
    Tuberculosis (Edinb); 2007 Nov 01; 87(6):526-34. PubMed ID: 17851131
    [Abstract] [Full Text] [Related]

  • 17. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF.
    Arthritis Rheum; 2005 Jan 01; 52(1):201-11. PubMed ID: 15641052
    [Abstract] [Full Text] [Related]

  • 18. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH, Mei MH, Fei R, Liu F, Wang JH, Liao WJ, Qin LL, Wei L, Chen HS.
    J Viral Hepat; 2010 Mar 01; 17 Suppl 1():34-43. PubMed ID: 20586932
    [Abstract] [Full Text] [Related]

  • 19. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
    Mahic M, Henjum K, Yaqub S, Bjørnbeth BA, Torgersen KM, Taskén K, Aandahl EM.
    Eur J Immunol; 2008 Mar 01; 38(3):640-6. PubMed ID: 18266270
    [Abstract] [Full Text] [Related]

  • 20. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.
    Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F.
    Cancer Res; 2005 Mar 15; 65(6):2457-64. PubMed ID: 15781662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 80.